Posted by Michael Wonder on 07 Jul 2020
Remove the disincentives and biosimilars will flourish, policy expert says
7 July 2020 - Patients could save as much as 17% on out-of-pocket costs if they used biosimilars, but many obstacles make that difficult to achieve.
Legislators have a lot of work to do to pull out the blocks and wedges that prevent full realisation of biosimilar savings.
